Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?

Lancet Oncology

Volumn 6, Issue 3, 2005, Pages 182-184

  Chevalier, Thierry Le ^a   Arriagada, Rodrigo ^a   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; UFT; VINCA ALKALOID; VINDESINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 14544295334     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)01769-9     Document Type: Note

References (19)

1. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 1995 809-09
2. Keller SM Adak S Wagner H et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer N Engl J Med 343 2000 1217-22
3. Waller D Peake MD Stephens RJ et al. Chemotherapy for patients with non-small cell lung cancer: The surgical setting of the Big Lung Trial Eur J Car Thorac Surg 26 2004 173-82
4. Scagliotti GV Fossati R Torri V et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453-61
5. International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351-60
6. Winton TL, Livingston R, Johnson D, et al. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10. Proc Am Soc Clin Oncol 2004; 22: Abstr 7018.
7. Strauss GM, Herndon J, Maddaus MA, et al, for the Cancer and Leukemia Group B (CALGB). Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2004; 22: Abstr 7019.
8. Hamada C, Ohta M, Wada H, et al. Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer. Proc Am Soc Clin Oncol 2004, 22: Abstr 7002.
9. Kato H, Ichinose Y, Ohta M, et al, for the Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004; 350: 1713-21.
10. Sedrakyan A van Der Meulen J O'Byrne K et al. Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis J Thorac Cardiovasc Surg 128 2004 414-19
11. Burdett S Auperin A Pignon JP Stewart L. Chemotherapy in non-small-cell lung cancer: An update of an individual patient data meta-analysis J Clin Oncol 23 2005 924-25
12. Fayers PM Ashby D Parmar MKB. Bayesian data monitoring in clinical trials Stat Med 16 1997 1413-1430
13. Depierre A. Milleron B Moro-Sibilot D et al. Preoperative chemotherapy followed by surgery compared with primary surgery in respectable stage I (except T1N0), II, IIIa non-small cell lung cancer J Clin Oncol 20 2001 247-53
14. Wu Y Huang Z Wang S et al. A randomised trial of systematic nodal dissection in resectable non-small cell lung cancer Lung Cancer 36 2002 1-6
15. Ambrogi V Pompeo E Elia S et al. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small cell lung cancer Eur J Cardiovasc Surg 23 2003 811-17
16. Pastorino U Valente M Bedini V et al. Effect of chronic cardiopulmonary disease on survival after resection for stage Ia lung cancer Thorax 37 1982 680-83
17. Wu Y Lin CJ Hsu W et al. Long-term results of pathological stage I non-small cell lung cancer: Validation of using the number of totally removed lymph nodes as a staging system Eur J Cardiovasc Surg 24 2003 994-1001
18. Pytynia KB Grant JR Etzel CJ et al. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck J Clin Oncol 22 2004 3981-88
19. Hotta K Matsuo K Ueoka H et al. Role of adjuvant chemotherapy in patients with resected non-small cell lung cancer: Reappraisal with a meta-analysis of randomised controlled trials J Clin Oncol 22 2004 3960-67